Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison.

Kumra S, Kranzler H, Gerbino-Rosen G, Kester HM, De Thomas C, Kafantaris V, Correll CU, Kane JM.

Biol Psychiatry. 2008 Mar 1;63(5):524-9.

PMID:
17651705
2.

Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study.

Kumra S, Kranzler H, Gerbino-Rosen G, Kester HM, DeThomas C, Cullen K, Regan J, Kane JM.

J Child Adolesc Psychopharmacol. 2008 Aug;18(4):307-16. doi: 10.1089/cap.2007.0089.

3.

A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.

Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, Anil Yağcioğlu AE, Small JG.

J Clin Psychiatry. 2008 Feb;69(2):274-85.

PMID:
18232726
4.

Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.

Shaw P, Sporn A, Gogtay N, Overman GP, Greenstein D, Gochman P, Tossell JW, Lenane M, Rapoport JL.

Arch Gen Psychiatry. 2006 Jul;63(7):721-30.

PMID:
16818861
5.

Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia.

Kelly DL, Conley RR, Richardson CM, Tamminga CA, Carpenter WT Jr.

Ann Clin Psychiatry. 2003 Sep-Dec;15(3-4):181-6.

PMID:
14971863
6.

Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.

Kane JM, Marder SR, Schooler NR, Wirshing WC, Umbricht D, Baker RW, Wirshing DA, Safferman A, Ganguli R, McMeniman M, Borenstein M.

Arch Gen Psychiatry. 2001 Oct;58(10):965-72.

PMID:
11576036
7.

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.

Bitter I, Dossenbach MR, Brook S, Feldman PD, Metcalfe S, Gagiano CA, Füredi J, Bartko G, Janka Z, Banki CM, Kovacs G, Breier A; Olanzapine HGCK Study Group..

Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):173-80.

PMID:
14687871
8.

Olanzapine versus placebo in adolescents with schizophrenia: a 6-week, randomized, double-blind, placebo-controlled trial.

Kryzhanovskaya L, Schulz SC, McDougle C, Frazier J, Dittmann R, Robertson-Plouch C, Bauer T, Xu W, Wang W, Carlson J, Tohen M.

J Am Acad Child Adolesc Psychiatry. 2009 Jan;48(1):60-70. doi: 10.1097/CHI.0b013e3181900404.

PMID:
19057413
9.

Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine.

Tollefson GD, Birkett MA, Kiesler GM, Wood AJ; Lilly Resistant Schizophrenia Study Group..

Biol Psychiatry. 2001 Jan 1;49(1):52-63.

PMID:
11163780
10.

A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.

McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH.

J Clin Psychiatry. 2004;65 Suppl 18:47-56.

11.

Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.

J Clin Psychiatry. 2002 Oct;63(10):931-5.

PMID:
12416603
12.

The effects of clozapine on symptom clusters in treatment-refractory patients.

Abraham G, Nair C, Tracy JI, Simpson GM, Josiassen RC.

J Clin Psychopharmacol. 1997 Feb;17(1):49-53.

PMID:
9004057
13.

Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.

Martín J, Gómez JC, García-Bernardo E, Cuesta M, Alvarez E, Gurpegui M.

J Clin Psychiatry. 1997 Nov;58(11):479-83.

PMID:
9413413
14.

Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents.

Kumra S, Jacobsen LK, Lenane M, Karp BI, Frazier JA, Smith AK, Bedwell J, Lee P, Malanga CJ, Hamburger S, Rapoport JL.

J Am Acad Child Adolesc Psychiatry. 1998 Apr;37(4):377-85.

PMID:
9549958
15.

[Prescription of olanzapine in children and adolescent psychiatric patients].

Frémaux T, Reymann JM, Chevreuil C, Bentué-Ferrer D.

Encephale. 2007 Mar-Apr;33(2):188-96. Review. French.

PMID:
17675914
16.

Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

Bondolfi G, Dufour H, Patris M, May JP, Billeter U, Eap CB, Baumann P.

Am J Psychiatry. 1998 Apr;155(4):499-504.

PMID:
9545995
17.

Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2002 Feb;159(2):255-62. Erratum in: Am J Psychiatry 2002 Dec;159(12):2132.

PMID:
11823268
18.

Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study.

Kluge M, Schuld A, Himmerich H, Dalal M, Schacht A, Wehmeier PM, Hinze-Selch D, Kraus T, Dittmann RW, Pollmächer T.

J Clin Psychopharmacol. 2007 Dec;27(6):662-6.

PMID:
18004133
19.
20.

Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.

Krakowski MI, Czobor P, Nolan KA.

J Clin Psychopharmacol. 2008 Oct;28(5):485-93. doi: 10.1097/JCP.0b013e3181855cd6.

PMID:
18794642
Items per page

Supplemental Content

Support Center